NanoLogix is a biotechnology company that produces rapid diagnostic products. The company produces test kits ideal for use in the rapid detection of live cell microorganisms present in infectious and noninfectious human diseases, the environment, industrial settings, veterinary medicine, and research and testing laboratories. Its customers include medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments.
The company has been issued 33 patents, applicable in the areas of applied microbiology, soil microbiology, medical diagnostics, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and hydrogen generation through use of bioreactors.